Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kiniksa Pharmaceuticals Ltd.

23.08
+0.47002.08%
Post-market: 23.080.00000.00%16:05 EDT
Volume:396.10K
Turnover:9.10M
Market Cap:1.68B
PE:-38.17
High:23.11
Open:22.68
Low:22.54
Close:22.61
Loading ...

Kiniksa Pharmaceuticals International, plc Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Simply Wall St.
·
01 Nov 2024

Kiniksa Pharmaceuticals Faces Financial Risks from Global Currency Fluctuations

TIPRANKS
·
31 Oct 2024

Kiniksa Pharmaceuticals International Third Quarter 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
30 Oct 2024

Analysts’ Top Healthcare Picks: BioMarin Pharmaceutical (BMRN), Kiniksa Pharmaceuticals (KNSA)

TIPRANKS
·
30 Oct 2024

Q3 2024 Kiniksa Pharmaceuticals Ltd Earnings Call

Thomson Reuters StreetEvents
·
30 Oct 2024

Kiniksa Pharmaceuticals International PLC (KNSA) Q3 2024 Earnings Call Highlights: Impressive ...

GuruFocus.com
·
30 Oct 2024

Kiniksa Pharmaceuticals Down Over 12%, on Pace for Largest Percent Decrease Since August 2021 -- Data Talk

Dow Jones
·
29 Oct 2024

Kiniksa Pharmaceuticals trading resumes

TIPRANKS
·
29 Oct 2024

Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
29 Oct 2024

Kiniksa Pharmaceuticals Q3 Loss Narrows, Revenue Rises

MT Newswires Live
·
29 Oct 2024

BRIEF-Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results And Recent Portfolio Execution

Reuters
·
29 Oct 2024

Kiniksa Pharmaceuticals Expects 2024 Arcalyst Net Product Revenue Of $410M-$420M Compared To Prior Guidance Of $405M-$415M

Benzinga
·
29 Oct 2024

Kiniksa Pharmaceuticals Q3 2024 GAAP EPS $(0.18) May Not Be Comparable To $0.04 Estimate, Sales $112.21M Beat $111.52M Estimate

Benzinga
·
29 Oct 2024

Kiniksa Pharmaceuticals Ltd: Expects 2024 Arcalyst Net Product Revenue of Between $410 Mln and $420 Mln

THOMSON REUTERS
·
29 Oct 2024

Kiniksa Pharmaceuticals Partners with GRAMMY® Award-Winning Singer-Songwriter, Carly Pearce, in Expansion of Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis

GlobeNewswire
·
28 Oct 2024

Press Release: Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024

Dow Jones
·
23 Oct 2024